# Faeth Therapeutics, Inc.: Form SC 13D/A, filed Jun 2, 2023

- Company: [Faeth Therapeutics, Inc.](/companies/fth.md) (CIK 1829802)
- Form: SC 13D/A
- Filed: 2023-06-02
- Accepted by EDGAR: Jun 2, 2023, 17:00 ET
- Period: not reported
- Accession: 0000921895-23-001419
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1829802/000092189523001419/sc13da513506002_06022023.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1829802/000092189523001419/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1829802/000092189523001419/sc13da513506002_06022023.htm

Filed Jun 2, 2023.
Source: SEC EDGAR, the filing index for accession 0000921895-23-001419. Last ingested by Listed: Nov 3, 2026, 23:17 ET. No prices; not investment advice.